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Am J Med Genet Part A 170A:2031–2038.FKBP14-related Ehlers–Danlos syndrome (EDS) is an extremely
rare recessive connective tissue disorder described for the first
time in 2012 by Baumann and coworkers. The causal gene,
FKBP14, encodes a member of the F506-binding family of
peptidyl-prolyl cis-trans isomerases. The paucity of patients
described so far makes this disorder poorly defined at clinical
level. Here, we report an additional pediatric patient, who is
compound heterozygous for a recurrent and a novel FKBP14
mutation, and compare his phenotype with those available in
literature. This evaluation confirms that kyphoscoliosis (either
progressive or non-progressive), myopathy, joint hypermobil-
ity, and congenital hearing loss (sensorineural, conductive, or
mixed) are the typical features of the syndrome. Since the patient
showed a severe cardiovascular event in childhood and atlan-
toaxial instability, this report expands the phenotype of the
disorder and the allelic repertoire of FKBP14.
 2016 Wiley Periodicals, Inc.
Key words: Ehlers–Danlos syndrome; FKBP14; vascular com-
plications; joint hypermobility; kyphoscoliosis; atlantoaxial
instabilityConflict of interest: none
Correspondence to:
Prof. Marina Colombi, Department of Molecular and Translational
Medicine, Division of Biology and Genetics, School of Medicine,
University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
E-mail: marina.colombi@unibs.it
Article first published online in Wiley Online Library
(wileyonlinelibrary.com): 5 May 2016
DOI 10.1002/ajmg.a.37728INTRODUCTION
Ehlers–Danlos syndromes (EDS) are clinically and genetically
heterogeneous connective tissue disorders (CTDs) characterized
by involvement of skin, joints, ligaments, vasculature, and internal
organs [Steinmann et al., 2002]. Six EDS types are included in the
Villefranche nosology [Beighton et al., 1998] and several rare
variants were more recently delineated [Colombi et al., 2015].
Among these, Baumann et al. [2012] reported a rare recessive
variant of EDS characterized by joint hypermobility, progressive
kyphoscoliosis, myopathy, and sensorineural hearing loss due to
recessive mutations in FKBP14. This gene encodes amember of the
F506-binding family of peptidyl-prolyl cis-trans isomerases found
in the lumen of the endoplasmic reticulum, where it is thought to2016 Wiley Periodicals, Inc.catalyze cis-trans-isomerization of peptidyl-prolyl peptide bonds
and to accelerate protein folding, particularly of procollagens
[Galat, 2003]. To date, eight patients with FKBP14-related EDS
from seven independent families have been described: five pediatric
(12 years), one young woman (16 years), and two adults (48 and
42-year-old) [Baumann et al., 2012; Aldeeri et al., 2014; Murray
et al., 2014].
Here we report an 8-year-old patient affected by FKBP14-related
EDS due to compound heterozygosity for a recurrent and a novel
FKBP14mutation and compare the proband’s clinical presentation
with the features of the patients available in literature. Our patient
presented with vascular rupture at 6 years and showed atlantoaxial
instability, never described before in FKBP14-related EDS, thus
expanding the clinical phenotype of this rare disorder.2031
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The patient, an 8-year-old Italianmale, was born from healthy non-
consanguineous parents at 36weeks by cesarean for cephalic pre-
sentation.Atbirth,measurementswerewithinnormal range (weight
3rd–15th centile, length 50th centile). Perinatal presentation was
abnormal, with severe muscle hypotonia and poor suck. Newborn
hearing screening with Auditory Brainstem Response Audiometry
suggested congenital bilateral profound hearing loss. He underwent
transtympanic drains due to impaired middle ear ventilation;
audiometric testing, performed subsequently, revealed a partial
improvement of hearing loss. At age 8 years, he had mixed hearing
loss ofmild degree. Grossmotormilestones were delayed; hewalked
without help at the age of 2.6 years. Non-progressive and non-
surgical kyphoscoliosis was first observed at 6months and success-
fully treated with lumbar orthosis. At the age 2 years, EDS VIA was
excluded by lysyl pyridinolines to hydroxylysyl pyridinoline
(LP/HP) urinary ratio analysis, which resulted within the normalFIG. 1. Radiological and physical findings of the patient. A: Atlanto-axial
(arrow). Thoraco-abdominal MRA performed after endovascular procedure
7 years (c); Cystography with contrast at 7 years showing a large left po
skin redundancy, elongated philtrum, micrognathia (a); enlarged post-bio
joints of hands and elbow (d–f); generalized muscle hypotonia and atrop
mild pectus excavatum, leg length discrepancy, valgus knee, and pes pla
article, available at http://wileyonlinelibrary.com/journal/ajmga].range. A flexion extension radiograph of the cervical spine per-
formed at the age 6 years revealed an asymptomatic atlantoaxial
instability with enlarged atlanto-epistropheal distance in flexion
(Fig. 1A, a,b).
Given generalized muscle hypotonia, at age 3 years primary
myopathy was suspected and histopathological examination of
muscle biopsy specimens revealed changes in muscle fiber diam-
eters, which were first linked to a nemaline myopathy. ACTA1,
TPM2, and TPM3 molecular analysis involved in nemaline
myopathy types 3, 4, and 1, respectively were negative. Muscle
hypotonia slowly improved with psychomotor rehabilitation pro-
grams. At age 6 years, the patient was admitted to emergency unit
for acute abdomen caused by left hypogastric artery pseudoaneur-
ysm rupture, safely treated with endovascular procedure
(Fig. 1A, c). Thoracic and abdominal magnetic resonance angiog-
raphy (MRA) performed after the vascular event did not show
other arterial malformations, such as ectasia, aneurysm, pseudoa-
neurysm, or tortuosity. Echocardiogram was normal. At ageinstability (a,b) with enlarged atlanto-epistropheal distance in flexion
for left hypogastric artery pseudoaneurysm rupture (arrow) at
stero-lateral bladder diverticulum (d); B: Epicanthal folds, palpebral
ptic scar (b); umbilical skin redundancy (c); hypermobility of the
hy, mild kyphoscoliosis, hyperlordosis, winged scapulae, genua valga,
nus (g, h). [Color figure can be seen in the online version of this
FIG. 2. Sequence chromatograms showing the positions of the

DORDONI ET AL. 20338 years, an asymptomatic arachnoid cyst of the dorsal spine was
successfully surgically removed. Diagnostic evaluation for voiding
dysfunction, in particular urinary retention, lead to the diagnosis of
a large bladder diverticulum by ultrasound; uroflussometry per-
formed at the age of 8 revealed detrusor dyssynergia of I–II grades
(Fig. 1A, d). The patient used braces for ankle instability from 3 to
5 years. At age 6, vitamin D supplementation was initiated due to
radiological findings of osteopenia.
The patient came to our attention at age 8 years; clinical exami-
nation revealed normal stature (1.27m, 25th–50th centile) and
weight (22 kg, 10th–25th centile), generalized muscle hypotonia
with myopathic gait, palpebral and umbilical skin redundancy,
epicanthal folds, periorbital creases, light blue sclerae, long phil-
trum, micrognathia, bifid uvula, an atrophic scar on the knee, an
enlarged scar after muscle biopsy, joint hypermobility according to
Beighton score (6/9), high palate, winged scapulae, kyphoscoliosis
of mild degree, mild pectus excavatum, bilateral valgus elbow,
valgus knee, and pes planus (Fig. 1B).
recurrent and paternal inherited c.362dup (p.Glu122Argfs 7)
and the novel maternal c.573_575del (p.Glu191del) mutations
that were detected in the proband in compound heterozygosity
in exon 3 and exon 4 of FKBP14, respectively. Mutations are
annotated according to HGVS nomenclature (http://www.hgvs.
org/mutnomen; seq. refs: NM_017946.3; NP_060416.1). [Color
figure can be seen in the online version of this article, available
at http://wileyonlinelibrary.com/journal/ajmga].MOLECULAR CHARACTERIZATION
After informed consent was obtained from the parents, molecular
characterization was performed on genomic DNA purified from
peripheral blood leukocytes using standard procedures. All exons
and intron-flanking regions of FKBP14 were PCR amplified by
using optimized genomic primer sets, as previously described
[Baumann et al., 2012]. PCR products were purified with
ExoSAP-IT (USB Corporation, Cleveland, OH) followed by bidi-
rectional sequencing with the BigDye Terminator v1.1 Cycle
Sequencing kit on an ABI 3130XL Genetic Analyzer (Applied
Biosystems, Carlsbad, CA). FKBP14 sequence analyses revealed
compound heterozygosity for the paternal and recurrent c.362dup
(p.Glu122Argfs7) and the maternal novel c.573_576del
(p.Glu191del) mutations (Fig. 2), thus confirming the diagnosis
of FKBP14-related EDS.DISCUSSION
The clinical presentation of the patient reported here was strongly
suggestive for FKBP14-related EDS, as he showed all the typical
signs of this extremely rare CTD, that is, kyphoscoliosis, muscle
hypotonia, and hearing loss. In addition to these cardinal features,
at age 6 years, he had a left hypogastric artery dissection, and
atlantoaxial instability. Clinical features and biochemical findings
of the nine patients affected by FKBP14-related EDS, proven by
molecular analysis, are summarized in Tables I and II, respectively.
Differential diagnosis should take into account other EDS types
with early onset/congenital kyphoscoliosis and myopathic signs,
that is, EDS kyphoscoliotic type, CHST14-related EDS, in addition
to CTDs with vascular involvement including EDS vascular type,
Marfan and Loeys–Dietz syndromes, and myopathies, particularly
those with joint laxity, such as Ullrich congenital dystrophy and
Bethlemmyopathy. The hearing loss distinguishes FKBP14-related
EDS from these disorders. Moreover, FKBP14-related EDS differs
from EDS kyphoscoliotic type by the normal ratio of urinary
LP/HP crosslinks [Rohrbach et al., 2011], from CHST14-related
EDS by the absence of congenital contracture of thumbs andfingers, and from the above mentioned CTDs with vascular in-
volvement by the absence of a typical facial appearance and visceral
rupture, marfanoid habitus, craniosynostosis, and widespread
aortic/arterial aneurysms [Colombi et al., 2015]. Absence of respi-
ratory muscle failure, improvement of muscle hypotonia with age
and presence of an unspecific myopathic pattern on electrophysi-
ological and muscle biopsy studies are useful aids to differentiate
FKBP14-related EDS form primary myopathies [Baumann et al.,
2012].
All the reported FKBP14-related EDS patients showed the
cardinal features of the disease, that is, hearing loss, early-onset
kyphoscoliosis, and myopathic signs, though with high variability
(Table I). Hearing impairment can vary from sensorineural (6/8),
to conductive (1/8), or mixed (present case) (Table I). In our
patient, because of the mixed origin of this sign, hearing improved
after transtympanic drains. Kyphoscoliosis is noted at a mean of
12months (range 2–18months) and it can be non-progressive
(three patients including ours) or progressive (6). Orthotic treat-
ment seemed successful in case of non-progressive kyphoscoliosis,
as in our patient; progressive kyphoscoliosis required a surgical
approach. Myopathic signs include muscle hypotonia and atrophy
(9/9), poor head control in infancy (7/7), and delayed motor
development (9/9) (Table I). Muscular weakness seems to regress
with age and all of the subjects-but one-became able to walk at the
mean age of 33months. The outcome is very variable and the final
ability to walk ranges frommyopathic gait, impossibility of walking
without aids, to a motor self-sufficiency from 200m to 1 km
(Table I). Muscle biopsy always shows pathological results with
a broad spectrum of findings; creatine kinase generally results
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DORDONI ET AL. 2037within the normal range (5/7) and electromyographic pattern can
vary with age (Table II).
In addition to these hallmarks, FKBP-14-related EDS patients
show a variable constellation of signs due to connective tissue
impairment affecting ocular, mucocutaneous, skeletal, nervous
central, and cardiovascular systems (Table I). The cardiovascular
risk in FKBP14-related EDS is not well defined (Table I). Vascular
complications are described in P8 (Table I), who presented a celiac
artery pseudoaneurysm rupture at the age of 41, and in the older
sister of P3 (Table I), likely affected but without molecular confir-
mation, who died due to unspecified aortic rupture at age 12 years.
Celiac artery pseudoaneurysm rupture was observed in our patient
at age 6 (Fig. 1). Atlantoaxial instability is reported here for the first
time, the other patients presented uncomplicated joint hypermo-
bility without recurrent dislocations/sprains or chronic pain (mean
value of Beighton score 7/9) (Table I). Facial dysmorphisms are not
always described and a facial “gestalt” is not recognizable, some
patients had epicanthal folds (3/3), micrognathia (3/4), hypotelor-
ism (1), square nasal root (1), or long-narrow face (1) (Table I).
Height is generally within the normal range, but at lower level
(10th–25th centile in 4 of 8), two patients had short stature (lower
than third centile) (Table I). Tissue fragility in FKBP14-related EDS
may lead to large bladder diverticulum (Fig. 1) or rectal prolapse
(present case).
In conclusion, our report supports many of the clinical data
available in literature for FKBP14-related EDS, confirming the
variability observed for the cardinal features. In addition, this
report describes a potentially life-threatening vascular complica-
tion in early pediatric age and atlantoaxial instability, suggesting
the need for FKBP14-related EDS patients of tailored follow-up
that includes cardiovascular monitoring, that is, cerebral, thoracic
and abdominal MRA, and cervical dynamic radiograph. Further
studies are needed to better delineate the phenotype of FKBP14-
related EDS.ACKNOWLEDGMENTS
The authors thank the patient’s parents for their cooperation
during the diagnostic process of their son.
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